Article
Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial.
Aging - 19 Dec 2020
Zhou Mengyuan, Chen Weiqi, Pan Yuesong, Lin Yi, Meng Xia, Zhao Xingquan, Liu Liping, Lin Jinxi, Li Hao, Wang Yongjun, Wang Yilong
Abstract excerpt
Studies on antiplatelet effect of ticagrelor/aspirin and clopidogrel/aspirin in patients with acute minor stroke and transient ischemic attack (TIA) stratified by CYP2C19 metabolizer status is limited. We gained data from the Platelet Reactivity In Non-disabling Cerebrovascular Events study. Platelet reactivity was tested at baseline, 2 hours, 24 hours, 7 days and 90 days after initial dose, including high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.